Zhongyuan Concord (600645.SH) released 2023 annual results, with net profit of 106 million yuan, a year-on-year decrease of 5.78%

Zhongyuan Concord (600645.SH) released its 2023 annual report. The company achieved operating income of 15 during the reporting period...

Zhitong FinanceApr 25 22:48

Express News | 5 companies disclose buyback progress

BreakingsApr 15 07:41

Zhongyuan Xiehe (600645.SH): A total of 4.7712 million shares have been repurchased

Gelonghui, April 14, 丨 Zhongyuan Xiehe (600645.SH) announced that as of April 12, 2024, the company had repurchased a total of 47712 million shares of the company through centralized bidding transactions, accounting for 1.02% of the company's total share capital, an increase of 0.28% compared with the previous disclosure. The highest purchase price was 17.50 yuan/share, the lowest price was 15.73 yuan/share, and the total amount paid was 78.21,500 yuan (not including transaction commissions and other fees).

Gelonghui FinanceApr 14 15:46

Zhongyuan Concord (600645.SH): A total of 3.4699 million shares have been repurchased

Gelonghui, April 1, 丨 Zhongyuan Xiehe (600645.SH) announced that in order to protect the company's value and shareholders' rights, as of March 31, 2024, the company had repurchased 3.469,900 shares of the company's shares through centralized bidding transactions, accounting for 0.74% of the company's total share capital. The highest purchase price was 17.50 yuan/share, the lowest price was 15.73 yuan/share, and the total amount paid was 573.34 million yuan (excluding transaction fees and other fees).

Gelonghui FinanceApr 1 16:59

The Five-year Loss for Vcanbio Cell & Gene Engineering (SHSE:600645) Shareholders Likely Driven by Its Shrinking Earnings

Ideally, your overall portfolio should beat the market average. But every investor is virtually certain to have both over-performing and under-performing stocks. At this point some shareholders may

Simply Wall StMar 15 07:23

Express News | Zhongyuan Kyowa: The subsidiary VUM02 injection was used to treat the first case of idiopathic pulmonary fibrosis to complete group administration

BreakingsMar 14 16:01